Tanzania PrePex™ Acceptability and Safety Study (TZ-Pass)

Multiple studies have shown that VMMC can prevent heterosexual HIV infection in uninfected men by up to 60 percent, and, as a result, WHO and UNAIDS recommend the promotion of male circumcision as part of a comprehensive HIV treatment package. Given the limited financial and human resources available to reach recommended VMMC targets in Tanzania, use of devices such as PrePex™, which accomplish VMMC nonsurgically and can be performed by mid-level health care providers in a nonsterile setting, may make it easier to reach recommended national targets.
This report presents findings from the Tanzania PrePex™ Acceptability and Safety Study (TZ-PASS), which was a pilot study to determine the benefits, acceptability, and risks of the PrePex™ device for nonsurgical circumcision in routine clinical settings in three regions in Tanzania. The study examined clinical outcomes, healing time, and client and partner views on the experience of circumcision with this device.